Lauren Roland, MD
Otolaryngology · Saint Louis, MONPI 1790072460
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,430 of the $10,853 with a category attached, or 96.1%. 7 manufacturers reported payments, led by Sanofi at 54.2% of the total. 2024 is the largest year on record at $5,907, more than ten times the $36 reported in 2019. Among otolaryngology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 9 payments — averaging $1205.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$6K
- GSK$5K
- Aerin Medical Inc.$228
- Medtronic$87
- Alk-abello, Inc$55
- Integra Lifesciences Corporation$27
- plus $25 from 1 others
What the payments were for
- Consulting fees$10,43096%
- Food & beverage$4234%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 1 | $5,880 |
| GSK | 1 | $4,550 |
| Aerin Medical Inc. | 1 | $228 |
| Medtronic | 1 | $87 |
| Alk-abello, Inc | 3 | $55 |
| Integra Lifesciences Corporation | 1 | $27 |
| Optinose US, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$4,550
- VIVAER STYLUS$228
- RHINAER STYLUS$228
How this compares
$10,853 in reported general payments places this provider in the 95th percentile of 210 otolaryngology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 38 | $1,008 |
| Azelastine Hcl | 71 | $999 |
| Fluticasone Propionate | 70 | $558 |
| Doxycycline Hyclate | 14 | $128 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $93 |
| Mupirocin | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Saint Louis
- Ryan JacksonSaint Louis$284K
- Ravindra UppaluriSaint Louis$168K
- John SchneiderSaint Louis$74K
- Amit WaliaSaint Louis$21K
- Bharat PanugantiSaint Louis$19K
- Cristine Klatt-CromwellSaint Louis$13K
- James HartmanSaint Louis$7K
- Robert ObertSaint Louis$7K
- Barry RosenblumSaint Louis$4K
- Arya NaminSaint Louis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.